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Introduction. Antimicrobial resistance is a global public health problem that the 
world is facing today.
Material and methods. Isolation and identification of Salmonella spp. were per-
formed according to DSTU EN 12824: 2004; DSTU ISO 18593: 2006 standards; Nutri-
ent media were manufactured in accordance with DSTU EN ISO 11133: 2014 standard. 
The antibiotic susceptibility of cultures was determined by the disk diffusion method. 
The research findings were both studied and interpreted in accordance with EUCAST 
recommendations.
Results. Out of 10 samples (material was obtained from animals, humans and foods), 
10 cultures of Salmonella spp. were isolated and analyzed. The cultures were mainly 
susceptible to semisynthetic and inhibitor-protected penicillins, cephalosporins, car-
bapenems and more often to tetracyclines, macrolides, lincosamides. Most Salmonella 
spp. strains were intermediate susceptibility to aminoglycosides, 30% of Salmonella 
spp. strains were susceptible to pefloxacin (II) and only 10% were susceptible to cipro-
floxacin (II).
Conclusions. The obtained data indicate the screening feasibility of antibiotic suscep-
tibility of Salmonella spp. including a wide range of tested drugs, which may be impor-
tant in determining the antibiotic therapy.
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STUDIEREA SENSIBILITĂŢII LA ANTIBIOTICE A SPECIILOR DE SALMONELLA, 
IZOLATE DIN MATERIALE BIOLOGICE ȘI PRODUSE ALIMENTARE
Introducere. Actualmente, rezistența antimicrobiană este o problemă globală de 
sănătate publică.
Material şi metode. Izolarea și identificarea Salmonella spp a fost efectuată conform 
standardelor DSTU EN 12824:2004; DSTU ISO 18593:2006; mediile nutritive fiind 
preparate în conformitate cu standardul DSTU EN ISO 11133:2014. Sensibilitatea 
tulpinilor la antibiotice a fost determinată prin metoda disc-difuzimetrică, iar studiul 
și interpretarea rezultatelor au fost realizate în conformitate cu recomandările EU-
CAST.
Rezultate. Din 10 probe (material prelevat de la animale, oameni și din alimente) au 
fost izolate și studiate 10 tulpini de Salmonella spp. Preponderent, tulpinile sunt sensi-
bile la penicilinele de semisintetice şi cele protejate de inhibitori, cefalosporine, carbap-
eneme; mai frecvent prezentând rezistență la tetracicline, macrolide și lincosamide. 
Pentru aminoglicozide însă majoritatea tulpinilor Salmonella spp. au prezentat sen-
sibilitate intermediară, astfel, din 30% tulpini Salmonella spp. sensibile la pefloxacină 
(II), doar 10% au fost sensibile la ciprofloxacină (II).
Concluzii. Datele obținute indică fezabilitatea screening-ului sensibilității Salmonella 
spp. la antibioticele din cea mai largă listă posibilă de preparate testate, impunându-se 
drept acțiune oportună în determinarea antibioticoterapiei.
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INTRODUCTIONOver the XXI century, infectious diseases are sti-ll the main causes of death worldwide (1, 2). Recently, the spread of antibiotic-resistant mi-croorganisms has become a public concern. Anti-microbials have been used in the production of li-vestock products for therapeutic and prophylactic purposes, which contributed to the development of adaptive mechanisms to the applied antibiotics. This, in turn, served as an impetus for the produc-tion of new antimicrobial agents.The Ukrainian agriculture sector shows a con-siderable sample size among global production volumes (3, 4). An increase in both the demand and production volume of agricultural products is accompanied by a free section of the continental 
boundaries of semi-finished or finished agri-fo-od products (5). Migration of people, birds and terrestrial wild animals also has contributed to the microbial long-distance transfer (5, 6, 7, 8). All these factors have differently promoted the spread of multi-resistant microbial strains to the existing antibiotics both due to their transportation by li-ving organisms over long distances, and due to the production of the agro-industrial complex. 
The purpose of this work is to study the biological properties and assess the antibiotic resistance among various groups Salmonella spp. cultures, isolated from biological samples taken from Kiev, Volyn region. 
MATERIAL AND METHODS
Salmonella spp. strains were isolated and iden-
tified from the research materials according to: DSTU EN 12824:2004 Microbiology of food pro-ducts and animal nutrition. Horizontal method for detecting Salmonella spp.; DSTU 4769:2007 Bacteriological study of pathological material from animals. Methods of detecting salmonella; MU 4.2.2723-10 “Laboratory diagnostics of sal-monella, detection of Salmonella in food products and environmental objects”, 2010; DSTU ISO 18593:2006 “Microbiology of food products and 
animal nutrition. The study of microbial finger-printing and washings from the surface”. Antibio-tic susceptibility testing by disc diffusion method, 
using HiMedia’s discs. The research findings were studied and interpreted in accordance with EU-CAST guidelines (9).
RESULTS The microbial cultures were isolated during the microbiological assessment of materials taken from Kiev, Volyn region.
The study confirmed 6 samples of biomaterial, obtained from birds and 6 Salmonella spp. strains 
were identified: S. Typhimurium (from geese), S. Virchow (from ducks), S.Virchow (from chickens), 
S. Gallinarum, S. Pullorum (from chickens), S. Ente-ritidis (from chickens) S. Dublin (from calf); two cultures – from food samples (S. Enteritidis, which are rare Salmonella species (F-67+) and two cultu-res (S. Enteritidis, S. Typhimurium) found in peo-ple with symptoms of food poisoning). The bacterial cultures formed a uniform turbidity and a small amount of white amorphous sediment in the Pepted Meat Broth, which was easily bro-ken-down while being shaken. The cultures of S. Dublin, S. Gallinarum, S. Pullorum formed growth rings. The bacterial cultures formed transparent, tender, greyish and 3-4 mm S-colonies in Meat In-fusion Agar. The laboratory animals (white mice weighing 16-18 g) which were subcutaneously administered doses of 0.5×109 CFU/cm3 died in 100% of experi-mental animals within 8 hours.
The research findings showed that the studied cul-tures in 100% of cases were susceptible to ampi-cillin and ampicillin/sulbactam, whereas were re-sistant to benzylpenicillin and methicillin; 90% of strains were resistant to oxacillin; 50% of cultures were susceptible to ticarcillin and 10% – resistant to ticarcillin/clavulanic acid; 30% of strains were susceptible and 60% were resistant to amoxicillin; 30% of cultures were susceptible 30% – resistant to piperacillin; 20% of strains were susceptible and 80% – resistant to carbenicillin. The structural similarity between cephalosporins and penicillins causes the same mechanism of an-timicrobial action and cross-allergies in some pa-tients (10, 11). The studied Salmonella spp. strains showed susceptibility to most of cephalosporins; no direct dependence of levels of antimicrobial susceptibility to various generation of drugs was found: 80% of the studied strains showed suscep-tibility and 10% showed resistance to cefazolin (I); 60% of cultures showed susceptibility and 30% showed resistance to cephalexin (I); 90% of the studied bacterial strains were susceptible and 10% of cultures were resistant to cefaclor (II).
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20% of the studied cultures were susceptible and 60% are resistant to cefuroxime (II); 90% of the studied cultures were susceptible to cefamandole (II), no resistant cultures were detected; 80% of the studied cultures were susceptible and 20% are 
resistant to cefixim (III); 30% of the studied cul-tures were susceptible and 30% were resistant to cefoperazone (III); 80% of the cultures of the stu-died cultures showed susceptibility to cefotaxim (III), no resistant cultures were detected; 50% of the studied bacterial strains showed susceptibility and 20% were resistant to ceftazidime (III); 20% of the studied strains were susceptible and 20% were resistant to ceftriaxone (III); 100% of the studied strains showed resistance to cefepim (IV).Due to the natural activity of carbapenems (imipe-nem and meropenem) against enterobacteria, the studied cultures were found susceptible to imipe-nem (70%) and meropenem (80%).No Salmonella spp. resistant to carbapenems was detected.The most studied cultures exhibited a moderate resistance to aminoglycosides: 20% of cultures were susceptible and 30% were resistant to strep-tomycin (I); 60% – susceptible and 10% – resis-tant to gentamicin (I); 20% – susceptible and 20% 
– resistant to kanamycin (I); 20% of cultures are susceptible and 80% – intermediate susceptible to neomycin (I); 40% –and 10% – resistant to tobramycin (II); except for netilin (II), to which 100% of the cultures were susceptible, and ami-kacin (III), which showed an inhibitory effect on 20% of the studied Salmonella spp. strains
Salmonella spp. have natural resistance to macroli-des (12, 13). Our studies also proved that Salmone-
lla spp. is resistant to macrolides. However, cultures of S. Gallinarum, S. Pullorum, S. Dublin, S. Virchow (Q) were susceptible to azithromycin (15); S. Virc-how (Q) strain was susceptible to clarithromycin.Most of the Salmonella spp. showed natural resis-tance to tetracyclines. The culture of S. Gallinarum Pullorum was susceptible to tetracycline, doxycy-cline; S. Typhimurium (F) showed sensitivity to Tetracycline.High concentrations of linquamides may also exhibit bactericidal effects to relatively high sus-ceptible microorganisms (13, 14). The studies conducted on microbial resistance to lincosami-des showed susceptibility to lincomycin and clin-damycin, except for S. Virchow (Q) strain.
Depending on the mechanism of action, quinolo-nes differ completely from other AMP drugs. 50% of Salmonella spp. were susceptible to nalidixic 
acid (I), norfloxacin (II), levofloxacin (III), and 
gatifloxacin (IV). The remaining drugs showed a 
susceptibility of 30% (pefloxacin (II) to 10% (ci-
profloxacin (II), оfloxacin (II), lomefloxacin (II)) of the studied cultures of Salmonella spp.Pathogenic microorganisms rarely develop anti-biotic resistance to nitrofurans. (19, 20, 21). The study results showed that 40% of the studied cul-tures were susceptibile to furazolidone.All the studied Salmonella spp. strains were sus-ceptibile to chloramphenicol
DISCUSSIONSTen Salmonella spp. strains were isolated from 10 samples of food products and biological material of various origin. Among the isolated cultures, 2 isolates belong to S. Enteritidis, 2- to S. Typhimu-rium, 2- to S. Virchow, 1- to S. Dublin, S. Gallina-rum, S. Pullorum, S. Muenchen, Salmonella F-67+. Cultural-morphological, enzymatic and antigenic properties of the selected cultures correspond to species characteristics; all bacterial cultures pro-ved to be pathogenic in white mice.The cultures were predominantly susceptible to semisynthetic and inhibitor-protected penici-llins, cephalosporins and carbapenems; cultures showed resistance to tetracyclines, macrolides, and lincosamides in most cases. As regarding the aminoglycosides, most of Salmonella spp. strains showed intermediate resistance; up to 50% of stu-died Salmonella spp. strains were susceptible to some quinolones of different generations, howe-ver, cultures showed resistance to an overwhel-ming number of cases; 30% of the selected Salmo-
nella spp. cultures were susceptible to amoxicillin, whereas the cultures were non-susceptible to ampicillin, a screening recommended by EUCAST (version 8) on the enterobacteria sensitivity to amoxicillin. From 30% of Salmonella spp. strains 
susceptible to pefloxacin (II) (EUCAST screening recommendations on susceptibility of Salmonella 
spp. to ciprofloxacin), 10% cultures showed sus-
ceptibility to ciprofloxacin (II). The study analysis found that the studied cultu-res isolated from food products, sick and dead animals, and biomaterial obtained from people were characterized by natural susceptibility to 
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antibiotics; no cases of acquired resistance was found within this study. This may indicate that, the current rational use of antibiotic therapy may be effective.
CONCLUSIONS1. The data obtained may indicate the need for screening studies on the susceptibility of Salmonella spp. strains to antibacterial drugs, while the list of studied drugs should be expanded as much as possible. It might be important when choosing an appropriate antibiotic therapy.
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